Author:
McDonald Michelle M.,Morse Alyson,Schindeler Aaron,Mikulec Kathy,Peacock Lauren,Cheng Tegan,Bobyn Justin,Lee Lucinda,Baldock Paul A.,Croucher Peter I.,Tam Patrick P. L.,Little David G.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference31 articles.
1. Levasseur R, Lacombe D, de Vernejoul MC (2005) LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders. Joint Bone Spine 72(3):207–214
2. Johnson ML (2004) The high bone mass family–the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuronal Interact 4(2):135–138
3. Wang C, Zhang G, Gu M, Zhou Z, Cao X (2014) Polymorphism of the low-density lipoprotein receptor-related protein 5 gene and fracture risk. Int J Clin Exp Med 7(12):5097–5103
4. Baron R, Rawadi G (2007) Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 5(2):73–80
5. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D’Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23(6):860–869
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献